Stabilized recombinant trefoil factor 2 (TFF2-CTP) enhances anti-tumor activity of PD-1 blockade in mouse models of colorectal cancer

被引：0

作者：

Kim, Woosook ^{[1
]}

Fu, Na ^{[1
]}

Duddempudi, Phaneendra ^{[2
]}

Dubeykovskaya, Zinaida ^{[3
]}

Almo, Steven ^{[2
]}

Guha, Chandan ^{[2
]}

Lederman, Seth ^{[4
]}

Wang, Timothy ^{[1
]}

机构：

[1] Columbia Univ, Med Ctr, New York, NY USA

[2] Albert Einstein Coll Med, New York, NY USA

[3] NYU, New York, NY USA

[4] Tonix Pharmaceut Inc, New York, NY USA

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-6640

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6640

引用

页数：2

共 50 条

[31] Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity [J].

Yue, Jiawei ;

Guo, Hui ;

Xu, Peng ;

Ma, Jinhong ;

Shi, Weifeng ;

Wu, Yumin .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (04)

[32] Cooperative anti-tumor effect of soluble NKG2D ligand MIC neutralization and PD-1 pathway blockade [J].

Basher, Fahmin ;

Wu, Jennifer .

JOURNAL OF IMMUNOLOGY, 2017, 198 (01)

[33] CCR2 Blockade Enhances Anti-tumor Immune Responses in Patients with Pancreatic Cancer [J].

Sanford, D. ;

Belt, B. ;

Panni, R. ;

Nywening, T. ;

Wang-Gillam, A. ;

Goedegebuure, P. ;

Linehan, D. .

ANNALS OF SURGICAL ONCOLOGY, 2014, 21 :S39-S39

[34] PD-1 regulates the anti-tumor immune function of macrophages through JAK2-STAT3 signaling pathway in colorectal cancer tumor microenvironment [J].

Jiang, Han ;

Pang, Jingjing ;

Li, Tengyue ;

Akofala, Atitso ;

Zhou, Xiaoxi ;

Yi, Changhua ;

Ning, Shangwei ;

Gao, Xu ;

Qiao, Yu ;

Kou, Jiayuan .

JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)

[35] Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer [J].

Chen, Jian ;

Zhu, Tianchuan ;

Jiang, Guanmin ;

Zeng, Qi ;

Li, Zhijian ;

Huang, Xi .

MOLECULAR CANCER, 2023, 22 (01)

[36] LAG-3 blockade enhances the anti-tumor efficacy of PD-1 blockade combined with radiotherapy in a syngeneic murine triple-negative breast cancer model Free [J].

Kim, Yoomin ;

Jeon, Seung Hyuck ;

Park, Nawon ;

Kim, Seongmin ;

Kim, In Ah .

CANCER RESEARCH, 2025, 85 (08)

[37] Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer [J].

Jian Chen ;

Tianchuan Zhu ;

Guanmin Jiang ;

Qi Zeng ;

Zhijian Li ;

Xi Huang .

Molecular Cancer, 22

[38] IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancer [J].

Somri-Gannam, Lina ;

Meisel-Sharon, Shilhav ;

Hantisteanu, Shay ;

Bar-Noy, Tomer ;

Sigal, Emiliya ;

Groisman, Gabriel ;

Hallak, Mordechai ;

Werner, Haim ;

Bruchim, Ilan .

FRONTIERS IN ONCOLOGY, 2024, 14

[39] PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells [J].

Parekh, Vrajesh V. ;

Lalani, Saif ;

Kim, Sungjune ;

Halder, Ramesh ;

Azuma, Miyuki ;

Yagita, Hideo ;

Kumar, Vipin ;

Wu, Lan ;

Van Kaer, Luc .

JOURNAL OF IMMUNOLOGY, 2009, 182 (05) :2816-2826

[40] Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models [J].

Lewis, Katherine E. ;

Selby, Mark J. ;

Masters, Gregg ;

Valle, Jose ;

Dito, Gennaro ;

Curtis, Wendy R. ;

Garcia, Richard ;

Mink, Kathy A. ;

Waggie, Kimberly S. ;

Holdren, Matthew S. ;

Grosso, Joseph F. ;

Korman, Alan J. ;

Jure-Kunkel, Maria ;

Dillon, Stacey R. .

ONCOIMMUNOLOGY, 2018, 7 (01)

← 1 2 3 4 5 →